[Revolution in anti-aging skincare] - New clinical publication validates the senomorphic properties of our anti-aging cream

We are delighted to announce the publication of our extensive research into Hyaluron Activ B3 Cellular Regenerating Cream, which marks a new era in skincare innovation. This groundbreaking study is the first to clinically validate the senomorphic properties of an anti-aging cream.

This remarkable achievement is the fruit of an inspiring collaboration between our research teams, led by Patrick BOGDANOWICZ, and the renowned Jean-Marc LEMAITRE, co-director of the Institut de Médecine Régénérative et des Biothérapies de Montpellier, a pioneer in cellular ageing research. Hyaluron Activ B3's innovative formula combines 6% niacinamide with two types of hyaluronic acid, targeting skin rejuvenation on multiple levels.

Watch as Dr Gautier Doat, Avène's Medical Director, reveals the key findings of this publication.